We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Boston Scientific's NIR stent -- a device designed and manufactured by Israel-based
Medinol that Boston Scientific no longer markets or sells -- was found to
infringe upon a single claim of Johnson & Johnson's (J&J's) Palmaz patent,
a Delaware jury ruled.
AngioScore, a developer of angioplasty tools for interventional cardiologists
and radiologists, announced the completion of the U.S. clinical trial for its
AngioSculpt Scoring Balloon Catheter in coronary lesions and the conclusion
of follow-up on the 200 patients in the trial.
Medical devicemaker Kensey Nash has received clearance from the FDA to sell
its TriActiv System in the U.S., and will launch the product through its new
direct sales force.
Nanogen, a developer of advanced diagnostic products, has been issued U.S. Patent
No. 6,867,048, "Multiplexed Active Biologic Array" by the U.S. Patent
and Trademark Office.
The Nellcor unit of Tyco International said that it would appeal a $420 million
award that it was ordered to pay for engaging in anticompetitive behavior in
the market for machines that measure the oxygen content in blood.
Biomarker Technologies, the worldwide technology provider of the blood diagnostic
test for the detection of breast cancer called the BT Test, announced plans
to begin a pilot study of the test in the U.S. beginning in April 2005.
Fort Worth, Texas-based Alcon has won government approval for the latest generation
of its intraocular lens for cataract patients, the company announced.
Eye Dynamics, a leading of health and safety products, announced it has signed
a letter of intent to acquire Superior, Colorado-based OrthoNetx, a provider
of medical devices for osteoplastic surgery.
Medical-test maker Dade Behring Holdings said it will enter into a new, multiyear
agreement with a consortium of banks to provide a $600 million revolving credit
facility for the company.
HealthTronics announced that it signed a new $125 million Senior Secured Term
Loan B, due 2011, and a definitive credit agreement for a new five-year $50
million revolving credit facility, due 2010.
Cardiac Science announced that physicians at the University of Michigan (UM)
Cardiovascular Center have launched a prospective study designed to assess the
effectiveness of the company's patented fully-automatic hospital bedside monitor-defibrillator,
the Powerheart Cardiac Rhythm Module (CRM), against the traditional hospital
"code blue" emergency response protocol.